{"entity":{"type":"insider","cik":"0001520041","url":"/insider/0001520041","json_url":"/insider/0001520041.json","name":"SAINTS CAPITAL GRANITE, L.P.","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":33,"n_filings":5,"first":"2013-03-28","last":"2013-10-16","span_basis":"filed_date"},"name_variants":[{"name":"SAINTS CAPITAL GRANITE, L.P.","source":"filing","n_filings":5,"first_seen":"2013-03-28","last_seen":"2013-10-16"}],"transactions":[{"id":4883746,"accession":"0001181431-13-054098","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0001181431-13-054098","line_url":"/filing/0001181431-13-054098","is_derivative":false,"issuer_cik":"0001177648","issuer_name":"ENANTA PHARMACEUTICALS INC","issuer_ticker":"ENTA","issuer_name_source":null,"issuer_url":"/issuer/0001177648","owner_cik":null,"owner_name":"Saints Capital Granite, LLC; OBP III - Holdings LLC; mRNA - Holdings LLC; SAINTS CAPITAL GRANITE, L.P.; OBP (Bermuda) III - Holdings LLC; OBP (Adjunct) III - Holdings LLC","owner_display_name":"Saints Capital Granite, LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":6,"other_reporting_owners":5,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":32103.0,"shares_display":"32,103","price_per_share":19.8287,"price_display":"19.83","price_state":"stated","total_value":636560.7561,"total_display":"636,560.76","total_whole":"636,561","shares_owned_after":1425708.0,"shares_owned_after_display":"1,425,708","ownership_form":"I","is_10b5_1":null,"transaction_date":"2013-10-14","filed_date":"2013-10-16","scope":"insider","n_lines":4},{"id":4883730,"accession":"0001181431-13-054098","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001181431-13-054098","line_url":"/filing/0001181431-13-054098","is_derivative":false,"issuer_cik":"0001177648","issuer_name":"ENANTA PHARMACEUTICALS INC","issuer_ticker":"ENTA","issuer_name_source":null,"issuer_url":"/issuer/0001177648","owner_cik":null,"owner_name":"Saints Capital Granite, LLC; OBP III - Holdings LLC; mRNA - Holdings LLC; SAINTS CAPITAL GRANITE, L.P.; OBP (Bermuda) III - Holdings LLC; OBP (Adjunct) III - Holdings LLC","owner_display_name":"Saints Capital Granite, LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":6,"other_reporting_owners":5,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":198.0,"shares_display":"198","price_per_share":21.05,"price_display":"21.05","price_state":"stated","total_value":4167.9,"total_display":"4,167.90","total_whole":"4,168","shares_owned_after":1451261.0,"shares_owned_after_display":"1,451,261","ownership_form":"I","is_10b5_1":null,"transaction_date":"2013-10-11","filed_date":"2013-10-16","scope":"insider","n_lines":4},{"id":5529555,"accession":"0001181431-13-053692","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0001181431-13-053692","line_url":"/filing/0001181431-13-053692","is_derivative":false,"issuer_cik":"0001177648","issuer_name":"ENANTA PHARMACEUTICALS INC","issuer_ticker":"ENTA","issuer_name_source":null,"issuer_url":"/issuer/0001177648","owner_cik":null,"owner_name":"SAINTS CAPITAL GRANITE, L.P.; mRNA - Holdings LLC; OBP III - Holdings LLC; OBP (Bermuda) III - Holdings LLC; OBP (Adjunct) III - Holdings LLC; Saints Capital Granite, LLC","owner_display_name":"SAINTS CAPITAL GRANITE, L.P.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":6,"other_reporting_owners":5,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":11207.0,"shares_display":"11,207","price_per_share":21.0563,"price_display":"21.06","price_state":"stated","total_value":235977.9541,"total_display":"235,977.95","total_whole":"235,978","shares_owned_after":1451419.0,"shares_owned_after_display":"1,451,419","ownership_form":"I","is_10b5_1":null,"transaction_date":"2013-10-10","filed_date":"2013-10-11","scope":"insider","n_lines":4},{"id":5529546,"accession":"0001181431-13-053692","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001181431-13-053692","line_url":"/filing/0001181431-13-053692","is_derivative":false,"issuer_cik":"0001177648","issuer_name":"ENANTA PHARMACEUTICALS INC","issuer_ticker":"ENTA","issuer_name_source":null,"issuer_url":"/issuer/0001177648","owner_cik":null,"owner_name":"SAINTS CAPITAL GRANITE, L.P.; mRNA - Holdings LLC; OBP III - Holdings LLC; OBP (Bermuda) III - Holdings LLC; OBP (Adjunct) III - Holdings LLC; Saints Capital Granite, LLC","owner_display_name":"SAINTS CAPITAL GRANITE, L.P.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":6,"other_reporting_owners":5,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":25000.0,"shares_display":"25,000","price_per_share":22.0,"price_display":"22.00","price_state":"stated","total_value":550000.0,"total_display":"550,000.00","total_whole":"550,000","shares_owned_after":1460339.0,"shares_owned_after_display":"1,460,339","ownership_form":"I","is_10b5_1":null,"transaction_date":"2013-10-09","filed_date":"2013-10-11","scope":"insider","n_lines":4},{"id":4396943,"accession":"0001181431-13-052691","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0001181431-13-052691","line_url":"/filing/0001181431-13-052691","is_derivative":false,"issuer_cik":"0001177648","issuer_name":"ENANTA PHARMACEUTICALS INC","issuer_ticker":"ENTA","issuer_name_source":null,"issuer_url":"/issuer/0001177648","owner_cik":null,"owner_name":"mRNA - Holdings LLC; Saints Capital Granite, LLC; OBP III - Holdings LLC; SAINTS CAPITAL GRANITE, L.P.; OBP (Adjunct) III - Holdings LLC; OBP (Bermuda) III - Holdings LLC","owner_display_name":"mRNA - Holdings LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":6,"other_reporting_owners":5,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4100.0,"shares_display":"4,100","price_per_share":22.846,"price_display":"22.85","price_state":"stated","total_value":93668.6,"total_display":"93,668.60","total_whole":"93,669","shares_owned_after":1480238.0,"shares_owned_after_display":"1,480,238","ownership_form":"I","is_10b5_1":null,"transaction_date":"2013-10-03","filed_date":"2013-10-04","scope":"insider","n_lines":4},{"id":4396917,"accession":"0001181431-13-052691","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001181431-13-052691","line_url":"/filing/0001181431-13-052691","is_derivative":false,"issuer_cik":"0001177648","issuer_name":"ENANTA PHARMACEUTICALS INC","issuer_ticker":"ENTA","issuer_name_source":null,"issuer_url":"/issuer/0001177648","owner_cik":null,"owner_name":"mRNA - Holdings LLC; Saints Capital Granite, LLC; OBP III - Holdings LLC; SAINTS CAPITAL GRANITE, L.P.; OBP (Adjunct) III - Holdings LLC; OBP (Bermuda) III - Holdings LLC","owner_display_name":"mRNA - Holdings LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":6,"other_reporting_owners":5,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8200.0,"shares_display":"8,200","price_per_share":23.6581,"price_display":"23.66","price_state":"stated","total_value":193996.42,"total_display":"193,996.42","total_whole":"193,996","shares_owned_after":1483501.0,"shares_owned_after_display":"1,483,501","ownership_form":"I","is_10b5_1":null,"transaction_date":"2013-10-02","filed_date":"2013-10-04","scope":"insider","n_lines":4},{"id":5236296,"accession":"0001144204-13-053716","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0001144204-13-053716","line_url":"/filing/0001144204-13-053716","is_derivative":false,"issuer_cik":"0001177648","issuer_name":"ENANTA PHARMACEUTICALS INC","issuer_ticker":"ENTA","issuer_name_source":null,"issuer_url":"/issuer/0001177648","owner_cik":null,"owner_name":"SAINTS CAPITAL GRANITE, L.P.; OBP (Adjunct) III - Holdings LLC; Saints Capital Granite, LLC; OBP (Bermuda) III - Holdings LLC; OBP III - Holdings LLC; mRNA - Holdings LLC","owner_display_name":"SAINTS CAPITAL GRANITE, L.P.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":6,"other_reporting_owners":5,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":185700.0,"shares_display":"185,700","price_per_share":23.5406,"price_display":"23.54","price_state":"stated","total_value":4371489.42,"total_display":"4,371,489.42","total_whole":"4,371,489","shares_owned_after":1490028.0,"shares_owned_after_display":"1,490,028","ownership_form":"I","is_10b5_1":null,"transaction_date":"2013-10-01","filed_date":"2013-10-02","scope":"insider","n_lines":4},{"id":5236280,"accession":"0001144204-13-053716","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001144204-13-053716","line_url":"/filing/0001144204-13-053716","is_derivative":false,"issuer_cik":"0001177648","issuer_name":"ENANTA PHARMACEUTICALS INC","issuer_ticker":"ENTA","issuer_name_source":null,"issuer_url":"/issuer/0001177648","owner_cik":null,"owner_name":"SAINTS CAPITAL GRANITE, L.P.; OBP (Adjunct) III - Holdings LLC; Saints Capital Granite, LLC; OBP (Bermuda) III - Holdings LLC; OBP III - Holdings LLC; mRNA - Holdings LLC","owner_display_name":"SAINTS CAPITAL GRANITE, L.P.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":6,"other_reporting_owners":5,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":14300.0,"shares_display":"14,300","price_per_share":23.1298,"price_display":"23.13","price_state":"stated","total_value":330756.14,"total_display":"330,756.14","total_whole":"330,756","shares_owned_after":1637838.0,"shares_owned_after_display":"1,637,838","ownership_form":"I","is_10b5_1":null,"transaction_date":"2013-09-30","filed_date":"2013-10-02","scope":"insider","n_lines":4},{"id":5168992,"accession":"0001181431-13-019348","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001181431-13-019348","line_url":"/filing/0001181431-13-019348#line-4","is_derivative":false,"issuer_cik":"0001177648","issuer_name":"ENANTA PHARMACEUTICALS INC","issuer_ticker":"ENTA","issuer_name_source":null,"issuer_url":"/issuer/0001177648","owner_cik":null,"owner_name":"OBP III - Holdings LLC; SAINTS CAPITAL GRANITE, L.P.; Saints Capital Granite, LLC; mRNA - Holdings LLC; OBP (Bermuda) III - Holdings LLC; OBP (Adjunct) III - Holdings LLC","owner_display_name":"OBP III - Holdings LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":6,"other_reporting_owners":5,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":66474.0,"shares_display":"66,474","price_per_share":14.0,"price_display":"14.00","price_state":"stated","total_value":930636.0,"total_display":"930,636.00","total_whole":"930,636","shares_owned_after":102176.0,"shares_owned_after_display":"102,176","ownership_form":"I","is_10b5_1":null,"transaction_date":"2013-03-26","filed_date":"2013-03-28","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":0,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":0,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":0},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001177648","name":"ENANTA PHARMACEUTICALS INC","url":"/issuer/0001177648","role":"Ten percent owner","n_filings":5,"first_seen":"2013-03-28","last_seen":"2013-10-16"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001520041","retrieved_at":"2026-08-23T12:35:23+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}